Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1967 Mar;2(2):179-89.

Wiskott-Aldrich syndrome: review and report of a large family

Wiskott-Aldrich syndrome: review and report of a large family

E R Stiehm et al. Clin Exp Immunol. 1967 Mar.

Abstract

Wiskott–Aldrich syndrome is a sex-linked recessive antibody-deficiency syndrome characterized by thrombocytopenia, eczema and increased susceptibility to infection. All forms of therapy are notably unsuccessful and these patients succumb in the first decade.

Three cases of this syndrome are presented from a large family in which nine male infants have succumbed with manifestations of this disease. Two of the infants died at ages 10 months and 4 years respectively. A third child is alive at age 2. Serial quantitative immune globulin studies performed in two cases demonstrated markedly elevated γA, decreased γM and normal γG; levels of γM were initially normal but fell progressively as γA levels increased. The low levels of γM are probably a factor in their low or absent isoagglutinins, poor response to injected antigens, and increased susceptibility to infection; elevated γA levels may indicate immunologic unresponsiveness and/or a compensatory mechanism for the defect in γM synthesis.

In two of these patients prolonged trials (17 and 23 months) of periodic plasma infusions (15 ml/kg at 6-week intervals), accompanied by γ-globulin injections (0·1 ml/kg) were undertaken. Although no remarkable effects on the platelets or their resistance to infection was noted, we feel that some benefit might have accrued and that further trails are indicated.

PubMed Disclaimer

References

    1. Pediatrics. 1966 Feb;37(2):339-41 - PubMed
    1. Pediatrics. 1966 May;37(5):715-27 - PubMed
    1. Am J Med. 1966 May;40(5):805-15 - PubMed
    1. Pediatrics. 1954 Feb;13(2):133-9 - PubMed
    1. Pediatrics. 1957 Mar;19(3):351-61 - PubMed

Substances

LinkOut - more resources